Botulinum toxin (Dysport®) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study

OBJECTIVE—To define a safe and effective dose of Dysport for treating hip adductor spasticity.
METHODS—Patients with definite or probable multiple sclerosis, and disabling spasticity affecting the hip adductor muscles of both legs, were randomised to one of four treatment groups. Dysport (500, 1000,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Hyman, N, Barnes, M, Bhakta, B, Cozens, A, Bakheit, M, Kreczy-Kleedorfer, B, Poewe, W, Wissel, J, Bain, P, Glickman, S, Sayer, A, Richardson, A, Dott, C
Format: Artigo
Sprache:Inglês
Veröffentlicht: BMJ Group 2000
Schlagworte:
Papers
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC1736956/
https://ncbi.nlm.nih.gov/pubmed/10811692
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp.68.6.707
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge